SK278918B6 - Farmaceutický prostriedok proti vysokému krvnému t - Google Patents
Farmaceutický prostriedok proti vysokému krvnému t Download PDFInfo
- Publication number
- SK278918B6 SK278918B6 SK2270-92A SK227092A SK278918B6 SK 278918 B6 SK278918 B6 SK 278918B6 SK 227092 A SK227092 A SK 227092A SK 278918 B6 SK278918 B6 SK 278918B6
- Authority
- SK
- Slovakia
- Prior art keywords
- pharmaceutical composition
- phenylpropylamino
- ethoxycarbonyl
- oxo
- carboxylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH219191 | 1991-07-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK227092A3 SK227092A3 (en) | 1996-02-07 |
| SK278918B6 true SK278918B6 (sk) | 1998-04-08 |
Family
ID=4228024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK2270-92A SK278918B6 (sk) | 1991-07-23 | 1992-07-21 | Farmaceutický prostriedok proti vysokému krvnému t |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US5620975A (lv) |
| EP (1) | EP0524512B1 (lv) |
| JP (1) | JPH0680009B2 (lv) |
| KR (1) | KR100260479B1 (lv) |
| CN (1) | CN1040505C (lv) |
| AT (1) | ATE260661T1 (lv) |
| AU (1) | AU656207B2 (lv) |
| BG (1) | BG60949B1 (lv) |
| BR (1) | BR9202830A (lv) |
| CA (1) | CA2074039C (lv) |
| CZ (1) | CZ281691B6 (lv) |
| DE (1) | DE59209993D1 (lv) |
| DK (1) | DK0524512T3 (lv) |
| ES (1) | ES2215160T3 (lv) |
| HR (1) | HRP930953B1 (lv) |
| HU (1) | HU214029B (lv) |
| IE (1) | IE922378A1 (lv) |
| IL (1) | IL102541A (lv) |
| IS (1) | IS3887A (lv) |
| MX (1) | MX9204212A (lv) |
| MY (1) | MY118064A (lv) |
| NO (1) | NO301047B1 (lv) |
| NZ (1) | NZ243577A (lv) |
| PT (1) | PT524512E (lv) |
| RO (1) | RO110905B (lv) |
| RU (1) | RU2084225C1 (lv) |
| SK (1) | SK278918B6 (lv) |
| TW (1) | TW216770B (lv) |
| UY (1) | UY23449A1 (lv) |
| YU (2) | YU72392A (lv) |
| ZA (1) | ZA925322B (lv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59409631D1 (de) * | 1993-07-15 | 2001-02-15 | Hoffmann La Roche | Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält |
| IL131816A (en) | 1997-04-04 | 2003-06-24 | Exxon Res & Engineering Compan | Composite structures having high containment strength |
| US6608097B2 (en) | 2001-10-10 | 2003-08-19 | Aryx Therapeutics | Materials and methods for the treatment of hypertension and angina |
| US7687086B1 (en) | 2003-02-28 | 2010-03-30 | University Of Portland | Method for obtaining taxanes |
| EP2537534B1 (en) | 2011-06-22 | 2014-12-17 | Hexal AG | Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2128984B (en) * | 1982-05-12 | 1985-05-22 | Hoffmann La Roche | Diaza-bicyclic compounds |
| DE3542794A1 (de) * | 1985-12-04 | 1987-06-11 | Bayer Ag | Antihypertensives kombinationspraeparat |
| CA1319144C (en) * | 1986-11-14 | 1993-06-15 | Quirico Branca | Tetrahydronaphthalene derivatives |
| FR2607004B1 (fr) * | 1986-11-20 | 1990-06-01 | Synthelabo | Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine |
| US5110813A (en) * | 1987-09-15 | 1992-05-05 | Alcoholism And Drug Addiction Research Foundation | Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors |
| US4871731A (en) * | 1987-10-07 | 1989-10-03 | Marion Laboratories, Inc. | Captopril and diltiazem composition and the like |
| KR940005408B1 (ko) * | 1990-12-03 | 1994-06-18 | 만도기계 주식회사 | 파워 윈도우 모우터 회전자의 선단부 흔들림 측정장치 |
-
1992
- 1992-07-04 TW TW081105301A patent/TW216770B/zh active
- 1992-07-11 DK DK92111847T patent/DK0524512T3/da active
- 1992-07-11 PT PT92111847T patent/PT524512E/pt unknown
- 1992-07-11 DE DE59209993T patent/DE59209993D1/de not_active Expired - Fee Related
- 1992-07-11 AT AT92111847T patent/ATE260661T1/de not_active IP Right Cessation
- 1992-07-11 EP EP92111847A patent/EP0524512B1/de not_active Expired - Lifetime
- 1992-07-11 ES ES92111847T patent/ES2215160T3/es not_active Expired - Lifetime
- 1992-07-16 NZ NZ243577A patent/NZ243577A/en unknown
- 1992-07-16 ZA ZA925322A patent/ZA925322B/xx unknown
- 1992-07-16 CA CA002074039A patent/CA2074039C/en not_active Expired - Fee Related
- 1992-07-17 MX MX9204212A patent/MX9204212A/es active IP Right Grant
- 1992-07-17 IL IL10254192A patent/IL102541A/en not_active IP Right Cessation
- 1992-07-20 RU SU925052378A patent/RU2084225C1/ru not_active IP Right Cessation
- 1992-07-20 HU HU9202367A patent/HU214029B/hu not_active IP Right Cessation
- 1992-07-20 AU AU20416/92A patent/AU656207B2/en not_active Ceased
- 1992-07-21 CZ CS922270A patent/CZ281691B6/cs not_active IP Right Cessation
- 1992-07-21 MY MYPI92001289A patent/MY118064A/en unknown
- 1992-07-21 KR KR1019920012932A patent/KR100260479B1/ko not_active IP Right Cessation
- 1992-07-21 SK SK2270-92A patent/SK278918B6/sk unknown
- 1992-07-21 RO RO92-0990A patent/RO110905B/ro unknown
- 1992-07-21 BG BG96664A patent/BG60949B1/bg unknown
- 1992-07-22 IE IE237892A patent/IE922378A1/en not_active Application Discontinuation
- 1992-07-22 CN CN92108668A patent/CN1040505C/zh not_active Expired - Fee Related
- 1992-07-22 NO NO922903A patent/NO301047B1/no not_active IP Right Cessation
- 1992-07-22 UY UY23449A patent/UY23449A1/es not_active IP Right Cessation
- 1992-07-23 BR BR929202830A patent/BR9202830A/pt not_active Application Discontinuation
- 1992-07-23 IS IS3887A patent/IS3887A/is unknown
- 1992-07-23 YU YU72392A patent/YU72392A/sh unknown
- 1992-07-23 JP JP4216629A patent/JPH0680009B2/ja not_active Expired - Fee Related
- 1992-07-23 YU YU72392A patent/YU49198B/sh unknown
-
1993
- 1993-06-07 HR HR930953A patent/HRP930953B1/xx not_active IP Right Cessation
-
1994
- 1994-11-02 US US08/333,171 patent/US5620975A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI92904B (fi) | Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi | |
| HU199302B (en) | Process for producing synergic pharmaceutical compositions having hypotensive activity | |
| US6162802A (en) | Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor | |
| CZ226095A3 (en) | The use of anticonvulsive agents for preparing medicaments intended for treating neuronal degeneration caused by aids | |
| CZ20021116A3 (cs) | Synergické kombinace antagonisty receptoru NK1 a strukturálního analogu GABA | |
| SK278918B6 (sk) | Farmaceutický prostriedok proti vysokému krvnému t | |
| EP0471388B1 (de) | Mittel zur Behandlung der Herzinsuffizienz | |
| DE19815411A1 (de) | Thermogenese stimulierend wirksame Arzneimittel | |
| JPH0148245B2 (lv) | ||
| DE19849737A1 (de) | Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen | |
| US3360434A (en) | Method for reducing blood pressure with phenylalanine derivatives | |
| SK19192000A3 (sk) | Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia | |
| US3904758A (en) | Method of increasing wakefulness | |
| WO1992016229A1 (de) | Erzeugnisse, enthaltend verapamil und trandolapril | |
| DE3627613A1 (de) | Pharmazeutische zubereitung | |
| KR970006083B1 (ko) | 위장질환 치료용 의약 조성물 | |
| US4499106A (en) | Lipolytic composition and method of treating obesity | |
| US3622671A (en) | Substituted 3-hydrazino pyridazines as hypotensives | |
| JPS6110510A (ja) | 免疫抑制作用を有する新規な医薬組成物 | |
| EP0260527A2 (de) | Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Tromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung | |
| SE434119B (sv) | Antihypertensivt preparat i enhetsdosform, innehallande bl a 2-((2,6-diklorofenyl)amino)-2-imidazolin | |
| IE43955B1 (en) | Pharmaceutical composition and dosage units thereof | |
| HRP20040702A2 (en) | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors forpreventing heart failure and other age-related dysfunctions of organs, age-related diseases and forprolonging lifespan | |
| JPH0761939B2 (ja) | 脳への酸素供給を増進させる薬剤組成物および該薬剤組成物の製造方法 | |
| MXPA00000522A (en) | Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |